\
&
Contact us
Published on | 2 years ago
ProgrammesA call for a pilot European Fellowship Scheme for Researchers at Risk is currently open with deadline 7 September 2023. The indicative call budget is €6 million to fund one project. The main objective of the call is:
The European Fellowship Scheme for Researchers at Risk action was allocated to the Directorate-General for Education, Youth, Sport and Culture (DG EAC) and the implementation will be monitored by the European Research Executive Agency (REA). Please find in these two videos more information on the background and application procedure for this call.
Any questions on the call can be send to REA-MSCA-HE-RR@ec.europa.eu
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.